Virginia Retirement Systems
MLYS icon

Virginia Retirement Systems’s Mineralys Therapeutics MLYS Stock Holding History

Virginia Retirement Systems’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-12,350
Closed -$333K – 1332
2026
Q2 		$333K Buy
12,350
+2,600
+27% +$71.3K ﹤0.01% 1092
2026
Q1 		$264K Buy
9,750
+400
+4% +$11.7K ﹤0.01% 866
2025
Q4 		$339K Buy
+9,350
New +$375K ﹤0.01% 825

Other funds holding MLYS

Catalys Pacific
Catalys Pacific Tokyo, Japan $210M AUM 33.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Andera Partners
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Virginia Retirement Systems's MLYS Position: Q3 2026 in Review

Virginia Retirement Systems sold out of Mineralys Therapeutics (MLYS) in Q3 2026, closing a stake of 12,350 shares — an estimated $333K sold.

Virginia Retirement Systems first reported a position in MLYS in Q4 2025 and held it in 3 quarters. The position peaked at $339K in Q4 2025. 146 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.

  • Virginia Retirement Systems reported no remaining Mineralys Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Virginia Retirement Systems sold 12,350 Mineralys Therapeutics shares in Q3 2026, an estimated $333K.
  • Virginia Retirement Systems first reported a position in Mineralys Therapeutics in Q4 2025 and held it in 3 quarters.
  • Virginia Retirement Systems's Mineralys Therapeutics position peaked at $339K in Q4 2025.
  • 146 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.